Tumour type and size are high risk factors for the syndrome of "cerebellar" mutism and subsequent dysarthria

被引:130
|
作者
Catsman-Berrevoets, CE
Van Dongen, HR
Mulder, PGH
Geuze, DPY
Paquier, PF
Lequin, MH
机构
[1] Univ Rotterdam Hosp, Sophia Childrens Hosp, Dept Child Neurol, NL-3000 CB Rotterdam, Netherlands
[2] Univ Rotterdam Hosp, Sophia Childrens Hosp, Dept Child Neurosurg, NL-3000 CB Rotterdam, Netherlands
[3] Univ Rotterdam Hosp, Sophia Childrens Hosp, Dept Child Radiol, NL-3000 CB Rotterdam, Netherlands
[4] Erasmus Univ, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands
[5] Univ Antwerp, Sch Med, Dept Ear Nose & Throat Surg, B-2020 Antwerp, Belgium
[6] Erasme Univ Hosp, Dept Neurol, B-1070 Brussels, Belgium
来源
关键词
mutism and subsequent dysarthria; cerebellar tumour; risk factors;
D O I
10.1136/jnnp.67.6.755
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective-"Cerebellar mutis" and subsequent dysarthria (MSD) is a documented complication of posterior fossa surgery in children. In this prospective study the following risk factors for MSD were assessed: type, size and site of the tumour; hydrocephalus at presentation and after surgery, cerebellar incision site, postoperative infection, and cerebellar swelling. Methods-In a consecutive series of 42 children with a cerebellar tumour, speech and neuroradiological studies (CT and MRT) were systematically analysed preoperatively and postoperatively. Speech was assessed using the Mayo Clinic Lists and the severity of dysarthria using the Michigan rating scale. Results-Twelve children (29%) developed MSD postoperatively. The type of tumour, midline localisation, and vermal incision were significant single independent risk factors. In addition, an interdependency of possible risk factors (tumour>5 cm, medulloblastoma) was found. Conclusion-MSD often occurs after paediatric cerebellar tumour removal and is most likely after removal of a medulloblastoma with a maximum lesion diameter>5 cm.
引用
收藏
页码:755 / 757
页数:3
相关论文
共 50 条
  • [32] Low density lipoprotein particle size and risk factors of insulin resistance syndrome
    Friedlander, Y
    Kidron, M
    Caslake, M
    Lamb, T
    McConnell, M
    Bar-On, H
    ATHEROSCLEROSIS, 2000, 148 (01) : 141 - 149
  • [33] CONDITIONING FACTORS FOR HIGH CARDIOVASCULAR RISK IN PATIENTS WITH CUSHING SYNDROME
    Boero, Laura
    Manavela, Marcos
    Botta, Eliana
    Susana Mallea-Gil, Maria
    Katz, Debora
    Merono, Tomas
    Tetzlaff, Walter
    Martin, Maximiliano
    Gomez Rosso, Leonardo
    Danilowicz, Karina
    Brites, Fernando
    ENDOCRINE PRACTICE, 2015, 21 (07) : 734 - 742
  • [34] Higher prevalence of risk factors for type 2 diabetes mellitus and subsequent higher incidence in men
    Almdal, Thomas
    Scharling, Henrik
    Jensen, Jan Skov
    Vestergaard, Hertrik
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2008, 19 (01) : 40 - 45
  • [35] Risk Factors for First and Subsequent CVD Events in Type 1 Diabetes: The DCCT/EDIC Study
    Bebu, Ionut
    Schade, David
    Braffett, Barbara
    Kosiborod, Mikhail
    Lopes-Virella, Maria
    Soliman, Elsayed Z.
    Herman, William H.
    Bluemke, David A.
    Wallia, Amisha
    Orchard, Trevor
    Lachin, John M.
    DIABETES CARE, 2020, 43 (04) : 867 - 874
  • [36] Risk Factors for Sleep Apnea Syndrome in Nonobese Type 2 Diabetics
    Kawasaki, Satsuki
    Misawa, Haruo
    Kondo, Tetsuri
    Kondo, Yoshinobu
    Terauchi, Yasuo
    DIABETES, 2019, 68
  • [37] The interplay of cardiovascular risk factors in the metabolic syndrome and type 2 diabetes
    Betteridge, DJ
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2004, 6 (0G) : G3 - G7
  • [38] Risk factors of the diabetic foot syndrome in patients with type 2 diabetes
    Ducka, Bernadeta
    Strojek, Krzysztof
    CLINICAL DIABETOLOGY, 2012, 1 (04): : 138 - 145
  • [39] The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes - Implications for syndrome X
    Gaillard, TR
    Schuster, DP
    Bossetti, BM
    Green, PA
    Osei, K
    DIABETES CARE, 1997, 20 (05) : 745 - 752
  • [40] Localization, type, and size of stroke possible risk factors for developing poststroke epilepsy
    Zivadinovic, B.
    EPILEPSIA, 2023, 64 : 205 - 205